Active Ingredient: NISOLDIPINE
Proprietary Name: NISOLDIPINE
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 8.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A216606
Product Number: 001
Approval Date: Apr 10, 2023
Applicant Holder Full Name: AMTA LABS LTD
Marketing Status:
Discontinued
Patent and Exclusivity Information
